kyvero
Market leaders

JYNT

The Joint Corp. (JYNT)

Healthcare • Medical Care Facilities

StockNasdaqCMUnited StatesUS47973J1025

6.69 USD -1.62% today Updated 13 Nov 2026 14:03

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by The Joint Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 14:03. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 11 Mar 2027 in 118 days · 16:00 · estimate 0.18
Last results 0.13 vs 0.08 estimated 05 Nov 2026 · Beat +59.9%
Beat the estimate 6 of 12 4 missed · 0 in line
Average surprise -1,012.8% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

13 Sep 2023: reported 0.01 09/23 07 Mar 2024: reported -0.61 03/24 02 May 2024: estimate -0.01 02 May 2024: reported 0.09 05/24 07 Nov 2024: estimate -0.01 07 Nov 2024: reported 0.05 11/24 13 Mar 2025: estimate 0.02 13 Mar 2025: reported 0.17 03/25 08 May 2025: reported -0.03 05/25 07 Aug 2025: estimate -0.02 07 Aug 2025: reported -0.06 08/25 06 Nov 2025: reported 0.13 11/25 12 Mar 2026: estimate 0.04 12 Mar 2026: reported 0.06 03/26 07 May 2026: estimate 0.03 07 May 2026: reported 0.08 05/26 06 Aug 2026: estimate 0.07 06 Aug 2026: reported -0.01 08/26 05 Nov 2026: estimate 0.08 05 Nov 2026: reported 0.13 11/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
11 Mar 2027 16:00 0.18 — — Upcoming
05 Nov 2026 16:00 0.08 0.13 +59.9% Beat
06 Aug 2026 16:00 0.07 -0.01 -114.8% Miss
07 May 2026 16:00 0.03 0.08 +146.2% Beat
12 Mar 2026 16:00 0.04 0.06 +50.0% Beat
06 Nov 2025 16:00 — 0.13 — —
07 Aug 2025 16:00 -0.02 -0.06 -242.9% Miss
08 May 2025 16:00 — -0.03 -800.9% Miss
13 Mar 2025 16:00 0.02 0.17 +1,000.7% Beat
07 Nov 2024 16:00 -0.01 0.05 +487.1% Beat
08 Aug 2024 16:00 -0.01 — +80.0% —
02 May 2024 16:00 -0.01 0.09 +1,482.3% Beat
07 Mar 2024 16:00 — -0.61 -12,196.0% Miss
09 Nov 2023 16:00 0.01 — -92.0% —
13 Sep 2023 16:00 — 0.01 — —
04 May 2023 16:00 -0.01 -0.03 -130.3% Miss
09 Mar 2023 16:00 0.07 0.04 -40.9% Miss
03 Nov 2022 16:00 0.06 0.05 -10.2% Miss
05 Aug 2022 09:00 -0.01 0.03 +377.7% Beat
05 May 2022 16:00 0.04 -0.01 -131.8% Miss
24 Feb 2022 16:00 0.04 0.02 -60.6% Miss
04 Nov 2021 16:00 0.03 0.13 +331.2% Beat
05 Aug 2021 16:00 0.06 0.18 +216.7% Beat
06 May 2021 16:00 0.05 0.16 +201.1% Beat
04 Mar 2021 16:00 0.13 0.74 +483.9% Beat
05 Nov 2020 16:00 -0.01 0.11 +1,749.2% Beat
06 Aug 2020 16:00 -0.13 0.01 +104.7% Beat
07 May 2020 17:00 0.06 0.06 -2.1% Miss
05 Mar 2020 16:00 0.07 0.09 +27.7% Beat
07 Nov 2019 16:00 0.03 0.04 +33.3% Beat
08 Aug 2019 16:00 0.04 0.03 -11.7% Miss
09 May 2019 16:00 0.03 0.07 +145.5% Beat
07 Mar 2019 16:00 0.03 0.06 +81.0% Beat
08 Nov 2018 16:00 0.01 0.01 +16.9% Beat
09 Aug 2018 16:00 -0.01 0.01 +249.6% Beat
10 May 2018 16:00 -0.02 -0.03 -28.6% Miss
08 Mar 2018 16:00 -0.03 -0.02 +33.3% Beat
09 Nov 2017 16:00 -0.07 -0.03 +57.1% Beat
10 Aug 2017 16:00 -0.10 -0.08 +23.0% Beat
11 May 2017 16:00 -0.12 -0.13 -4.0% Miss
09 Mar 2017 16:00 -0.21 -0.45 -109.3% Miss
10 Nov 2016 16:00 -0.21 -0.21 +2.3% Beat
11 Aug 2016 16:00 -0.27 -0.26 +3.7% Beat
12 May 2016 16:00 -0.31 -0.28 +10.3% Beat
16 Mar 2016 16:00 -0.24 -0.31 -29.2% Miss
16 Nov 2015 08:00 -0.26 -0.17 +35.9% Beat
13 Aug 2015 16:00 -0.23 -0.19 +17.4% Beat
14 May 2015 16:00 -0.17 -0.18 -4.2% Miss
19 Mar 2015 16:00 -0.04 -0.35 -900.0% Miss
22 Dec 2014 09:00 -0.04 -0.04 -14.3% Miss

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 54.9M +5.2% 2.9M 5.3% 0.19 +133.3% 334.7K
2024 52.2M +11.0% -5.8M -11.1% -0.57 +13.6% 8.2M
2023 47M -53.6% -9.8M -20.8% -0.66 -925.0% 9.7M
2022 101.3M — 626.7K 0.6% 0.08 — 2.3M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
12 Nov 2026 6.77 6.77 6.61 6.69 -1.62% 63,100
11 Nov 2026 6.80 6.95 6.68 6.80 -0.44% 47,900
10 Nov 2026 6.65 6.89 6.58 6.83 +2.71% 58,600
09 Nov 2026 6.75 6.75 6.52 6.65 -2.92% 377,300
06 Nov 2026 6.63 7.34 6.63 6.85 -7.06% 151,100
05 Nov 2026 7.51 7.63 7.37 7.37 -1.86% 57,500
04 Nov 2026 7.34 7.51 7.28 7.51 +4.31% 22,200
03 Nov 2026 7.32 7.38 7.09 7.20 -1.64% 42,600
02 Nov 2026 7.13 7.34 7.04 7.32 +4.13% 49,300
30 Oct 2026 7.32 7.40 6.83 7.03 -4.48% 74,800
1,249 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
6.80 USD
Market cap
91.6M
Exchange
NasdaqCM
Country
United States
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 12.5 / 25
  • Revenue growth of -18.5% a year
  • Earnings per share growth of 33.4% a year
Quality Return on equity, net margin and how stable the margins are. 8.8 / 25
  • ROE of 19%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 18.2 / 20
  • Net debt is -3.8× EBITDA
  • Free cash flow yield of 1.9%
Valuation Free cash flow yield and the P/E against its sector. 7.3 / 15
  • P/E 30.9 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 10.0 / 10
  • Analysts' target is +35% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 30.91× Weak 30.56×
P/E (forward) 10.79× Good 14.16×
Price / book 7.61× Weak 3.5×
Price / sales 1.59× Good 3.33×
EV / EBITDA 18.11× Weak 11.19×
Free cash flow yield 1.9% Weak 2.1%
Quality
FigureValueReading Sector median
Gross margin 82.3% Good 54.9%
Operating margin 4.6% Weak 5.8%
Net margin 4.8% Weak 1.2%
Return on equity 18.5% Good 4.4%
Return on assets 3.1% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year -18.5% Weak 10.1%
EPS growth / year 33.4% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.16× Good 0.4×
Net debt / EBITDA -3.82× Good 1.46×
Current ratio 1.96× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow JYNT and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in